In peptide research, AOD-9604 has emerged as a subject of significant scientific interest. Originally developed in the 1990s as a fragment of human growth hormone, this peptide has been studied primarily in the context of laboratory and pre-clinical research. While sometimes mentioned in popular discussions, it is important to emphasize that AOD-9604 is classified strictly as a research chemical and is not approved for human or veterinary use.
This article provides a compliance-ready overview of AOD-9604, outlining its background, research applications, and regulatory considerations — designed for laboratories, academic institutions, and professionals in the scientific community.
What Is AOD-9604?
- Structure: AOD-9604 is a modified fragment of the human growth hormone molecule, consisting of amino acids 176–191.
- Research Purpose: It was designed to investigate whether targeted fragments of growth hormone could elicit specific biological responses without the full systemic effects of the parent hormone.
- Purity Standards: In modern research, suppliers typically verify AOD-9604 using high-performance liquid chromatography (HPLC) and mass spectrometry to ensure >98–99% purity for laboratory applications.
Key Areas of Scientific Interest
(Note: All information below is presented for educational purposes only. No statements should be interpreted as medical advice or as an endorsement of use outside controlled laboratory settings.)
- Metabolic Research AOD-9604 has been investigated in laboratory models exploring how peptide fragments may influence metabolic pathways.
- Tissue Repair Studies Preliminary studies have explored whether AOD-9604 contributes to cellular signaling involved in repair processes.
- Comparative Peptide Research Scientists often study AOD-9604 alongside other growth hormone fragments to evaluate specificity, stability, and potential research applications.
Compliance and Regulatory Considerations
When working with peptides like AOD-9604, compliance is critical:
- For Research Use Only (RUO): AOD-9604 is not FDA-approved for therapeutic, diagnostic, or over-the-counter use. It is intended solely for in-vitro and laboratory research.
- Labeling Requirements: Researchers must ensure all vials and documentation clearly state “Not for human consumption.”
- Advertising Restrictions: Marketing language must avoid therapeutic claims. Blogs and websites should emphasize education, research context, and regulatory boundaries.
- Ethical Standards: Institutions should maintain strict protocols for sourcing, handling, and disposing of peptide materials in accordance with local and federal regulations.
Best Practices for Laboratories
- Source only from suppliers that provide Certificates of Analysis (COAs).
- Verify purity and sterility through independent lab testing where feasible.
- Maintain detailed logs of all experiments and disposal procedures.
- Stay updated on evolving guidance from the FDA, DEA, and other regulatory agencies.
AOD-9604 continues to hold value as a research subject for scientists studying peptide fragments and their roles in biological systems. By approaching it with compliance, transparency, and rigorous scientific standards, laboratories and academic institutions can contribute to the growing body of knowledge while staying aligned with ethical and regulatory requirements.
